Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“Peter Baker said the five-year delay is unnecessary.”
VerifiedConfidence: HIGH

Reasoning

The ProPublica article includes a direct quotation from Peter Baker: “If they wanted to do it in one year, they could… I would love to hear their justification on why they need five years… I mean, it’s a simple label change.” This confirms the claim that he said the five-year delay is unnecessary.

On confidence: The provided source directly quotes Peter Baker stating the five-year delay is unnecessary.

Important context

Peter Baker is identified as a former FDA inspector commenting on the timeline for new drug label regulations. The statement pertains specifically to the five-year period proposed for developing rules and guidance on transparency.

Evidence

Supporting (1)

Limitations

The evidence is limited to a single article excerpt; no additional sources were provided to corroborate the quote.

Last verified:
Sep 27, 2026, 4:24 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

“A Clear Watering Down”: Drug Transparency Bill Stripped of Critical Provisions Ahead of Senate Vote

ProPublica · Naisha Roy